Slide Insurance Holdings, Inc. (SLDE)
NASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
NASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
QuarterlyIQ Insights · SLDE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $25 the market pays 2.6× p/b — above the 1.7× p/b peer median but in line with its own 2× history. That premium reflects a durable franchise our peer-anchored $46 fair value understates; treat the 'expensive vs peers' read with low confidence. Analysts target $20–$28. Note: our $46 fair value sits above the entire analyst range ($20–$28). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $24.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $88.13 | — | — | Analyst | high |
| dcf fcff | 12M | $98.72 | — | — | Analyst | high |
| graham number | 12M | $29.42 | — | — | TTM | high |
| Peer P/B | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$20.00 – $28.00 (median $24.50) · 4 analysts · as of 2026-08-03
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $16.13 |
| 1.7 |
| 9.38 |
| TTM |
| high |
| Peer P/FCF | 12M | $55.06 | 6.8 | 8.13 | TTM | high |
| Peer P/E | 12M | $57.43 | 14.0 | 4.10 | TTM | high |
| Peer P/S | 12M | $15.58 | 1.4 | 10.91 | TTM | high |
| residual income | 12M | $22.20 | — | — | TTM | high |
| Own P/E history | 12M | $22.35 | 5.5 | 4.10 | TTM | high |
| triangulated | 12M | $65.28 | 14.0 | 4.66 | Triangulated | high |
| Peer P/E | 3Y | $45.61 | 14.0 | 3.26 | Analyst | medium |
| Peer P/S | 3Y | $27.32 | 1.4 | 19.13 | Analyst | medium |
| Own P/E history | 3Y | $17.75 | 5.5 | 3.26 | Analyst | medium |
| Peer P/E | 5Y | $39.11 | 14.0 | 2.79 | Analyst | high |
| Peer P/S | 5Y | $36.13 | 1.4 | 25.29 | Analyst | high |
| Own P/E history | 5Y | $15.22 | 5.5 | 2.79 | Analyst | high |